Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study

Diabetes Care

Volumn 26, Issue 9, 2003, Pages 2598-2603

  Raskin, Philip ^a   Bode, Bruce W ^b   Marks, Jennifer B ^c   Hirsch, Irl B ^d   Weinstein, Richard L ^e   McGill, Janet B ^f   Peterson, Gregory E ^g   Mudaliar, Sunder R ^h   Reinhardt, Rickey R ⁱ  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b ATLANTA DIABETES ASSOCIATES   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Diablo Clinical Research   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g Diagn and Critical Care Medicine PC   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ NOVO NORDISK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FATIGUE; FEMALE; HEART PALPITATION; HUMAN; HUNGER; HYPOGLYCEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PHYSICAL EXAMINATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWEATING; TREATMENT OUTCOME; TREMOR; VERTIGO;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT SATISFACTION; SAFETY; TREATMENT REFUSAL;

EID: 0042824199     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.9.2598     Document Type: Article

References (21)

1. Mecklenburg RS: Iinsulin-pump therapy. In Therapy for Diabetes Mellitus and Related Disorders. 3rd ed. Lebovitz H, Ed. Alexandria, VA, American Diabetes Association, 1998, p. 204-210
2. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19:324-327, 1996
3. Raskin P, Strowig SM, Davidson PC: Benefits of insulin pump therapy. In The Insulin Pump Therapy Book: Insights from the Experts. Fredrickson L, Ed. Symlar, CA, MiniMed Technologies, 1995, p. 10-19
4. Lauritzen T, Pramming S, Deckert T, Binder C: Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 24:326-329, 1983
5. The Diabetes Control and Complications Trial Research Group: Implementation of treatment protocols in the Diabetes Control and Complication Trial. Diabetes Care 18:361-375, 1995
6. Reynolds RL: Reemergence of insulin pump therapy in the 1990s. South Med J 93:1157-1161, 2000
7. Jennings AM, Lewis KS, Murdoch S, Talbot JF, Bradley C, Ward JD: Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas. Diabetes Care 14:738-744, 1991
8. Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA: Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus, a randomized clinical trial. JAMA 27:1322-1327, 1996
9. Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 20:1353-1356, 1997
10. Valensi P, Moura I, Le Magoarou M, Peries J, Perret G, Attali JR: Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin dependent overweight patients with poor glycemic control despite maximal oral anti-diabetic treatment. Diabete Metab 23:51-57, 1996
11. Zinman B, Tildesley H, Chiasson J-L, Tsui E, Strack T: Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 46:440-443, 1997
12. Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry R: Insulin aspart (B28 Asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care 22:1501-1506, 1999
13. Bode BW, Strange P: Efficacy, safety, and pump compatibility if insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Diabetes Care 24:69-72, 2001
14. Bode B, Weinstein R, Bell D, McGill J, Nadeau D, Raskin P, Davidson J, Henry R, Huang WC, Reinhardt RR: Comparison of insulin aspart to buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes. Diabetes Care 25:439-444, 2002
15. Bio-Rad Diamat Analyzer System Operations Manual. Richmond, CA, Bio-Rad, 1993
16. Ellis G, Diamandis EP, Giesbrecht EE, Daneman D, Allen LC: An automated high pressure liquid chromatographic assay for hemoglobin Alc. Clin Chem 30:1746-1752, 1984
17. Patient Satisfaction in Diabetesfor the Insulin Pump. Wellesley Hills, MA, PHASE V Technologies, 1999
18. Patient Satisfaction in Diabetes. Wellesley Hills, MA, PHASE V Technologies, 1998
19. Quality of Life in Diabetes. Wellesley Hills, MA, PHASE V Technologies, 1998
20. Testa MA, Hayes JF, Turner RR, Simonson DC: Patient acceptance and satisfaction with intensive insulin therapy in type 2 diabetes: a randomized trial of the insulin pen versus pump (Abstract). Diabetes 50 (Suppl. 2):A428, 2001
21. Turner RR, Testa MA, Hayes JF, Simonson DC: Patient satisfaction with intensive insulin therapy in type 2 diabetes: a randomized trial of insulin pen vs pump (Abstract). Diabetologia 44:A26, 2001